A group of 28 cancer patient advocacy organizations, including the American Cancer Society and Friends of Cancer Research, pressed FDA to set up a standalone Oncology Center of Excellence that includes drug, biologics and device experts to handle reviews of products designed to treat cancer. Their letter to the agency Monday (June 6) follows a proposal by Friends of Cancer Research to reorganize the agency's centers from product specific to disease specific, and comes on as Vice President Joe Biden's...